Biomimetic fibrin-hyaluronan hydrogels for nucleus pulposus regeneration

Regenerative Medicine

Volumn 9, Issue 3, 2014, Pages 309-326

  Li, Zhen ^a   Kaplan, Keren Mevorat ^b   Wertzel, Abraham ^b   Peroglio, Marianna ^a   Amit, Boaz ^b   Alini, Mauro ^a   Grad, Sibylle ^a   Yayon, Avner ^b  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b ProCore Biomed Ltd Weizman Science Park   (Israel)

Author keywords

Fibrinogen hyaluronan conjugate; Hydrogel; Intervertebral disc; Nucleus pulposus; Regeneration

Indexed keywords

BIOMIMETIC MATERIAL; FIBRIN; FIBRINOGEN; GLYCOSAMINOGLYCAN; HYALURONIC ACID; HYDROGEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE REGENERATION; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; HYDROGEL; IN VITRO STUDY; INTERVERTEBRAL DISK; NONHUMAN; NUCLEUS PULPOSUS; ORGAN CULTURE; PRIORITY JOURNAL; RIGIDITY; ANIMAL; BOVINAE; CELL CULTURE; CHEMISTRY; GENE EXPRESSION PROFILING; HISTOLOGY; INTERVERTEBRAL DISC DEGENERATION; LIQUID CHROMATOGRAPHY; NONPARAMETRIC TEST; PHYSIOLOGY; REGENERATION; THERAPEUTIC USE;

ANIMALS; BIOMECHANICAL PHENOMENA; BIOMIMETIC MATERIALS; CATTLE; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; FIBRIN; GENE EXPRESSION PROFILING; HISTOLOGICAL TECHNIQUES; HYALURONIC ACID; HYDROGELS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; REGENERATION; STATISTICS, NONPARAMETRIC;

EID: 84902597807     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.14.5     Document Type: Article

References (66)

1. Luo X, Pietrobon R, Sun SX et al. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine (Phila Pa 1976) 29, 79-86 (2004).
2. Grad S, Alini M, Eglin D et al. Cells and biomaterials for intervertebral disc regeneration. In: Synthesis Lectures on Tissue Engineering (Volume 2). Athanasiou KA (Ed.). Morgan & Claypool, CA, USA, 46-47 (2010).
3. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976) 31, 2151-2161 (2006).
4. Chan SC, Gantenbein-Ritter B. Intervertebral disc regeneration or repair with biomaterials and stem cell therapy-feasible or fictioñ Swiss Med. Wkly 142, 1-12 (2012).
5. Sakai D, Mochida J, Yamamoto Y et al. Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: A potential therapeutic model for disc degeneration. Biomaterials 24, 3531-3541 (2003).
6. Mizuno H, Roy AK, Zaporojan V et al. Biomechanical and biochemical characterization of composite tissue-engineered intervertebral discs. Biomaterials 27, 362-370 (2006).
7. Mwale F, Iordanova M, Demers CN et al. Biological evaluation of chitosan salts cross-linked to genipin as a cell scaffold for disk tissue engineering. Tissue Eng. 11, 130-140 (2005).
8. Sha'ban M, Yoon SJ, Ko YK et al. Fibrin promotes proliferation and matrix production of intervertebral disc cells cultured in three-dimensional poly(lactic-co-glycolic acid) scaffold. J. Biomater. Sci. Polym. Ed. 19, 1219-1237 (2008).
9. Gruber HE, Leslie K, Ingram J et al. Cell-based tissue engineering for the intervertebral disc: In vitro studies of human disc cell gene expression and matrix production within selected cell carriers. Spine J. 4, 44-45 (2004).
10. Cloyd JM, Malhotra NR, Weng L et al. Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds. Eur. Spine J. 16, 1892-1898 (2007).
11. Kogan G, Soltes L, Stern R et al. Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol. Lett. 29, 17-25 (2007).
12. Cheng YH, Yang SH, Su WY et al. Thermosensitive chitosan-gelatinglycerol phosphate hydrogels as a cell carrier for nucleus pulposus regeneration:an in vitro study. Tissue Eng. Part A 16, 695-703 (2010).
13. Peroglio M, Grad S, Mortisen D et al. Injectable thermoreversible hyaluronan-based hydrogels for nucleus pulposus cell encapsulation. Eur. Spine J. 21, 839-849 (2012).
14. Chou AI, Akintoye SO, Nicoll SB. Photo-crosslinked alginate hydrogels support enhanced matrix accumulation by nucleus pulposus cells in vivo. Osteoarthr. Cartil. 17, 1377-1384 (2009).
15. Reza AT, Nicoll SB. Characterization of novel photocrosslinked carboxymethylcellulose hydrogels for encapsulation of nucleus pulposus cells. Acta Biomater. 6, 129-186 (2010).
16. Moss IL, Gordon L, Woodhouse KA et al. A novel thiol-modified hyaluronan and elastin-like polypetide composite material for tissue engineeringv of the nucleus pulposus of the intervertebral disc. Spine (Phila Pa 1976) 36, 1022-1029 (2011).
17. Ferri F, Greco M, Arcovito G et al. Growth kinetics and structure of fibrin gels. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 63(3 Pt 1), 031401 (2001).
18. Wang MC, Pins GD, Silver FH. Preparation of fibrin glue: The effects of calcium chloride and sodium chloride. Mater. Sci. Eng. 3, 131-135 (1995).
19. Bilic G, Hall H, Bittermann AG et al. Human preterm amnion cells cultured in 3-dimensional collagen I and fibrin matrices for tissue engineering purposes. Am. J. Obstet. Gynecol. 193, 1724-1732 (2005).
20. Yang SH, Wu CC, Shih TTF et al. Three-dimensional culture of human nucleus pulposus cells in fibrin clot: Comparisons on cellular proliferation and matrix synthesis with cells in alginate. Artif. Organs 32, 70-73 (2008).
21. Yayon A, Neria E, Blumenstein S et al. BIOCART™II a novel implant for 3D reconstruction of articular cartilage. J. Bone Joint Surg. Br. 88B(Suppl. 2), 344 (2006).
22. Eshed I, Trattnig S, Sharon M et al. Assessment of cartilage repair after chondrocyte transplantation with a fibrin-hyaluronan matrix-correlation of morphological MRI, biochemical T2 mapping and clinical outcome. Eur. J. Radiol. 81, 1216-1223 (2012).
23. Park SH, Cui JH, Park SR et al. Potential of fortified fibrin/hyaluronic acid composite gel as a cell delivery vehicle for chondrocytes. Artif. Organs 33, 439-447 (2009).
24. Park SH, Park SR, Chung SI et al. Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Artif. Organs 29, 838-845 (2005).
25. Chiung LY, Hui WC, Tzu CW et al. A novel fibrin gel derived from hyaluronic acid-grafted fibrinogen. Biomed. Mater. 6, 1-11 (2011).
26. Amit B, Barkay-Olami H, Yayon A: EP2106263 A2 (2008).
27. Amit B, Barkay-Olami H, Yayon A: WO2007/067523 (2008).
28. Mackie IJ, Kitchen S, Machin SJ. Guidelines on fibrinogen fibrinogen assays. Br. J. Haematol. 121, 396-404 (2003).
29. Audrey P, Benno M, Peter B et al. Modulating rheological and degradation properties of temperature-responsive gelling systems composed of blends of PCLA-PEG-PCLA triblock copolymers and their fully hexanoyl-capped derivatives. Acta Biomater. 8, 4260-4267 (2012).
30. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883, 173-177 (1986).
31. Lee CR, Grad S, MacLean JJ et al. Effect of mechanical loading on mRNA levels of common endogenous controls in articular chondrocytes and intervertebral disk. Anal. Biochem. 341, 372-375 (2005).
32. Illien-Jünger S, Pattappa G, Peroglio M et al. Homing of mesenchymal stem cells in induced degenerative intervertebral discs in a whole organ culture system. Spine 37, 1865-1873 (2012).
33. Jünger S, Gantenbein-Ritter B, Lezuo P et al. Effect of limited nutrition on in situ intervertebral disc cells under simulated phsiological loading. Spine 34, 1264-1271 (2009).
34. Hoffman AS. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 54, 3-12 (2002).
35. Ahmed TA, Dare EV, Hincke M. Fibrin: A versatile scaffold for tissue engineeringapplications. Tissue Eng. B Rev. 14, 199-215 (2008).
36. Janmey PA, Winer JP, Weisel JW. Fibrin gels and their clinical and bioengineering applications. J. R. Soc. Interf. 6, 1-10 (2009).
37. Shaikh FM, Callanan A, Kavanagh EG et al. Fibrin: A natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188, 333-346 (2008).
38. Syedain ZH, Bjork J, Sando L et al. Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue. Biomaterials 30, 6695-6701 (2009).
39. Tuan TL, Song A, Chang S et al. In vitro fibroplasia: Matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp. Cell. Res. 223, 127-134 (1996).
40. Rowe SL, Stegemann JP. Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios. Biomacromolecules 7, 2942-2948 (2006).
41. Meinhart J, Fussenegger M, Hobling W. Stabilization of fibrin-chondrocyte constructs for cartilage reconstruction. Ann. Plast. Surg. 42, 673-678 (1999).
42. Lorentz KM, Kontos S, Frey P et al. Engineered aprotinin for improved stability of fibrin biomaterials. Biomaterials 32, 430-438 (2011).
43. Pereira RC, Scaranari M, Castagnola P et al. Novel injectable gel (system) as avehicle for human articular chondrocytes in cartilage tissue regeneration. J. Tissue Eng. Regen. Med. 3, 97-106 (2009).
44. Chou CH, Cheng WT, Kuo TF et al. Fibrin glue mixed with gelatin/hyaluronic acid/chondroitin-6-sulfate tri-copolymer for articular cartilage tissue engineering: The results of real-Time polymerase chain reaction. J. Biomed. Mater. Res. A 82, 757-767 (2007).
45. Halloran DO, Grad S, Stoddart M et al. An injectable crosslinked scaffold for nucleus pulposus regeneration. Biomaterials 29, 438-447 (2008).
46. Yang SH, Chen PQ, Chen YF, Lin FH. An in-vitro study on regeneration of human nucleus pulposus by using gelatin/chondroitin-6 sulfate/hyaluronan tri-copolymer scaffold. Artif. Organs 29, 806-814 (2005).
47. Ghosh P, Guidolin D. Potential mechanism of action of intra-Articular hyaluronan therapy in osteoarthritis: Are the effects molecular weight dependent? Semin. Arthritis Rheum. 32, 10-37 (2002).
48. Revell PA, Damien E, Di Silvio L et al. Tissue engineered intervertebral disc repair in the pig using injectable polymers. J. Mater. Sci. Mater. Med. 18, 303-308 (2007).
49. Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J. Biomed. Mater. Res. 47, 152-169 (1999).
50. Iatridis JC, Weidenbaum M, Setton LA et al. Is the nucleus pulposus a solid or a fluid? Mechanical behaviors of the nucleus pulposus of the human intervertebral disc. Spine 21, 1174-1184 (1996).
51. Jaques LB. Blood clotting and hemostasis. Ann. Rev. Physiol. 16, 175-214 (1954).
52. Eyrich D, Brandl F, Appel B et al. Long-Term stable fibrin gels for cartilage engineering. Biomaterials 28, 55-65 (2007).
53. Haberstroh K, Enz A, Zenclussen ML et al. Human intervertebral disc-derived cells are recruited by human serum and form nucleus pulposus-like tissue upon stimulation with TGF-beta3 or hyaluronan in vitro. Tissue Cell 41, 414-420 (2009).
54. Cavallo C, Desando G, Facchini A et al. Chondrocytes from patients with osteoarthritis express typical extracellular matrix molecules once grown onto a three-dimensional hyaluronan-based scaffold. J. Biomed. Mater. Res. A 93, 86-95 (2010).
55. Feng G, Li L, Liu H et al. Hypoxia differentially regulates human nucleus pulposus and annulus fibrosus cell extracellular matrix production in 3D scaffolds. Osteoarthr. Cartil. 21, 582-588 (2013).
56. Iatridis JC, MacLean JJ, Roughley PJ et al. Effects of mechanical loading on intervertebral disc metabolism in vivo. J. Bone Joint Surg. Am. 88(Suppl. 2), 41-46 (2006).
57. Chan SC, Ferguson SJ, Gantenbein-Ritter B. The effects of dynamic loading on the intervertebral disc. Eur. Spine J. 20, 1796-1812 (2011).
58. Li S, Jia X, Duance VC et al. The effects of cyclic tensile strain on the organisation and expression of cytoskeletal elements in bovine intervertebral disc cells: An in vitro study. Eur. Cell Mater. 21, 508-522 (2011).
59. Hegewald AA, Enz A, Endres M et al. Engineering of polymer-based grafts with cells derived from human nucleus pulposus tissue of the lumbar spine. J. Tissue Eng. Regen. Med. 5, 275-282 (2011).
60. Minogue BM, Richardson SM, Zeef LA et al. Transcriptional profiling of bovine intervertebral disc cells: Implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Res. Ther. 12, R22 (2010).
61. Rutges J, Creemers LB, Dhert W et al. Variations in gene and protein expression in human nucleus pulposus in comparison with annulus fibrosus and cartilage cells: Potential associations with aging and degeneration. Osteoarthr. Cartil. 18, 416-423 (2010).
62. Lee CR, Sakai D, Nakai T et al. A phenotypic comparison of intervertebral disc and articular cartilage cells in the rat. Eur. Spine J. 16, 2174-2185 (2007).
63. Minogue BM, Richardson SM, Zeef LA et al. Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation. Arthritis Rheum. 62, 3695-3705 (2010).
64. Power KA, Grad S, Rutges JP et al. Identification of cell surface-specific markers to target human nucleus pulposus cells: Expression of carbonic anhydrase XII varies with age and degeneration. Arthritis Rheum. 63, 3876-3886 (2011).
65. Pattappa G, Li Z, Peroglio M et al. Diversity of intervertebral disc cells: Phenotype and function. J. Anat. 221, 480-496 (2012).
66. Alini M, Eisenstein SM, Ito K et al. Are animal models useful for studying human disc disorders/degeneratioñ Eur. Spine J. 17, 2-19 (2008).